Your browser doesn't support javascript.
loading
How can we improve investigation, prevention and treatment for recurrent urinary tract infections - ICI-RS 2018.
Harding, Chris; Rantell, Angela; Cardozo, Linda; Jacobson, Susan Kim; Anding, Ralf; Kirschner-Hermanns, Ruth; Greenwell, Tamsin; Swamy, Sheela; Malde, Sachin; Abrams, Paul.
Afiliação
  • Harding C; Department of Urology, Freeman Hospital, Newcastle-upon-Tyne, UK.
  • Rantell A; Department of Urogynaecology, King's College Hospital, London, UK.
  • Cardozo L; Department of Urogynaecology, King's College Hospital, London, UK.
  • Jacobson SK; Infection Sciences, Severn Pathology, North Bristol NHS Trust, Bristol, UK.
  • Anding R; Department of Neuro-Urology/Urology, University Clinic, Friedrich Wilhelms University Bonn and Neurological Rehabilitation Center "Godeshöhe" e.V, Bonn, Germany.
  • Kirschner-Hermanns R; Department of Neuro-Urology/Urology, University Clinic, Friedrich Wilhelms University Bonn and Neurological Rehabilitation Center "Godeshöhe" e.V, Bonn, Germany.
  • Greenwell T; Department of Urology, University College London Hospital, London, UK.
  • Swamy S; Division of Medicine, University College London, London, UK.
  • Malde S; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Abrams P; Southmead Hospital, Bristol Urological Institute, Bristol, UK.
Neurourol Urodyn ; 38 Suppl 5: S90-S97, 2019 12.
Article em En | MEDLINE | ID: mdl-31821632
ABSTRACT

BACKGROUND:

Recurrent urinary tract infection (rUTI) is a chronic condition and has a significant impact on health-related quality of life. The commonly used definition for rUTI is greater than three episodes in a year or more than two in 6 months. Current diagnostic methods have been used worldwide for over five decades, despite well evidenced criticism. Enhanced culture techniques demonstrate that the microbiome of the bladder is far more complex than previously thought and begs a reappraisal of our current testing. Treatment of rUTI is based on a small number of antibiotic trials with some evidence showing a reduction in the number of positive cultures, but one must be cautious in interpreting the results and weigh against the risk of generation of antimicrobial resistance (AMR).

AIM:

The International Consultation on Incontinence-Research Society think tank reviewed the literature with a view to improving investigation, prevention and treatment of rUTI.

METHODS:

A multidisciplinary team of experts were invited to present evidence regarding the current diagnostic methods, recent advances related to bladder biome mapping and current treatment strategies, including antibiotic and nonantibiotic options. Current guidelines regarding antibiotic stewardship and concerns regarding AMR were discussed.

DISCUSSION:

Outcome of the think tank discussions are summarised with a set of recommendations to inform future research. Particular consideration is given to bacterial survival in the bladder after treatment as well as defects in urothelial barrier function which may play a significant part in the failure to eradicate UTI.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_doencas_nao_transmissiveis Assunto principal: Infecções Urinárias / Antibacterianos Tipo de estudo: Etiology_studies / Guideline / Qualitative_research / Risk_factors_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Neurourol Urodyn Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_doencas_nao_transmissiveis Assunto principal: Infecções Urinárias / Antibacterianos Tipo de estudo: Etiology_studies / Guideline / Qualitative_research / Risk_factors_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Neurourol Urodyn Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
...